This week, the OIG published its Mid-Year Update to its 2015 Work Plan, which we previously summarized. The Mid-Year Update adds several new monitoring activities to the existing Work Plan, summarized below.
We recently released our 2015 litigation trends annual survey, the 11th overall and the most extensive in its history. More than 800 corporate counsel representing companies across 26 countries were polled on disputes-related issues and concerns. Click here to read
On Friday, May 22, a Detroit-area neurosurgeon accused of performing medically unnecessary spinal surgeries pleaded guilty to health care fraud in two federal criminal cases. Dr. Aria Sabat, 39, admitted Friday before U.S. District Judge Paul Borman that his participation
On Tuesday, the U.S. Supreme Court handed down a ruling addressing two major False Claims Act (FCA) interpretive issues. First, the Court held that the Wartime Suspension of Limitations Act’s (WSLA) tolling of the statutes of limitations on claims
Two recent joint ventures demonstrate potential opportunities for health care providers to expand into the Chinese market.
The first venture involves Raffles Medical Group, a large Singapore-based health care provider, collaborating with Shanghai LuJiaZui (Group) Co, Ltd., a China real
A USDA report published earlier this month estimated that foodborne pathogens impose a $15.5 billion burden on the U.S. public annually. The report notes that there are 9.4 million foodborne-pathogen caused illnesses in the U.S. annually, despite the fact that
On May 19, 2015, the Food and Drug Administration (“FDA”) proposed a rule requiring animal drug manufacturers to track drug sales by species. Currently, manufacturers must track only total sales by drug class in accordance with the Animal Drug User
Under the auspices of increased transparency, on May 13, 2015, state senator Ruben Diaz (D-NY) introduced the “Pharmaceutical Cost Transparency Act of 2015” [Bill 5338] to the New York State Senate. The legislative intent is “to make pharmaceutical
On Thursday morning, May 21, the U.S. House of Representatives Energy and Commerce Committee by a unanimous vote passed the 21st Century Cures Act. The legislation as approved by the committee includes provisions addressing many areas of health care,
Earlier this week, the World Trade Organization rejected a US appeal of the WTO’s decision that country-of-origin-labeling (COOL) on beef and pork improperly discriminates against meat imports and to the benefit of domestic meat products. The WTO’s May 18 decision